Skip to main content
. 2020 Nov 30;11:608248. doi: 10.3389/fendo.2020.608248

Table 2.

Meal induced glucose and hormone responses in post-RYGB patients according to MMTT glycemic response (Hypo and NoHypo).

MMTT result
Hypo NoHypo p value
N (% of total) 11 (47.83) 12 (52.17%) NA
Glucose
Fasting (mmol/l) 4.5 ± 0.1 4.7 ± 0.3 0.324
iAUC0’-120’ (mmol/l x min) 223.5 ± 13.2 263.7 ± 27.5 0.214
Peak (mmol/l) 8.5 ± 0.3 9.6 ± 0.4 0.049
Nadir (mmol/l) 2.5 ± 0.1 4.0 ± 0.3 <0.001
MMGR 3.5 ± 0.2 2.5 ± 0.1 <0.001
Total AA
Fasting (µmol/l) 1394 ± 151.7 1396 ± 141.5 0.992
iAUC0’-120’ (µmol/l x min) 92400 ± 16433 95334 ± 12932 0.889
Insulin
Fasting (pmol/l) 40.9 (29.4–45.7) 32.8 (27.2–52.9) 0.576
iAUC0’-120’ (nmol/l x min) 99.1 (60.8–113.8) 45.4 (37.4–53.6) 0.019
IGI 44.4 (32.8–54.6) 24.9 (16.6–36.2) 0.007
OGIS [ml/(min x m2)] 395.9 (380.3–448.1) 401.6 (376.6–424.2) 0.695
Disposition Index 17646.2 ± 1385.6 10848.6 ± 1630.5 0.005
C-peptide
Fasting (pmol/l) 492.3 (435.5–602.9) 505.0 (375.1–544.8) 0.910
iAUC0’-120’ (nmol/l x min) 235.7 ± 17.2 168.4 ± 15.3 0.008
ISR
Fasting [pmol/(kg.min)] 1.7 (1.5–2.0) 1.6 (1.3–1.8) 0.518
iAUC0’-120’ (pmol/kg) 1016 ± 67.3 694.2 ± 60.3 0.002
ISRiAUC/GlucoseiAUC 323.5 ± 23.7 226.3 ± 34.8 0.034
Insulin Clearance
Fasting 3.0 ± 0.2 3.4 ± 0.3 0.369
Postprandial0’-120’ 0.8 (0.7–1.0) 1.2 (0.8–1.7) 0.079
Glucagon
Fasting (pmol/l) 5.8 ± 0.8 6.3 ± 0.8 0.695
iAUC0’-120’ (pmol/l x min) 869.3 ± 121.3 758.3 ± 124.8 0.532
GLP-1
Fasting (pmol/l) 21.1 ± 2.5 14.8 ± 2.4 0.080
iAUC0’-120’ (pmol/l x min) 7717 ± 958.1 6558 ± 725.3 0.341
GIP
Fasting (pmol/l) 4.0 (3.0–6.0) 6.0 (2.6–9.0) 0.384
iAUC0’-120’ (pmol/l x min) 4298 (3353–5689) 3683 (2607–5665) 0.339
Neurotensin
Fasting (pmol/l) 20.0 (18.0–24.0) 20.0 (20.0–27.0) 0.653
iAUC0’-120’ (pmol/l x min) 13440 (8940–20100) 12765 (10774–18764) 0.833

Results are presented as mean ± SEM or median (interquartile range). Statistically significant differences (p value <0.05) are highlighted in bold. MMTT, mixed-meal tolerance test; Hypo, individuals developing a glucose nadir <3.05 mmol/l during the MMTT; NoHypo, subjects with glucose levels ≥3.05 mmol/l during MMTT; MMGR, minimum-to-maximum glucose ratio; Total AA, total amino acids; IGI, insulinogenic index; OGIS, oral glucose insulin sensitivity; iAUC, postprandial incremental AUC; ISR, insulin secretion rate; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1.